Middle EAST Gastrointestinal Stromal Tumors Industry Growth Report: Key Drivers and Strategic Insights
The Middle EAST Gastrointestinal Stromal Tumors Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.10 billion by 2034, registering a CAGR of 9.1%. This growth trajectory is underpinned by several factors including the rising incidence of gastrointestinal stromal tumors (GISTs), advancements in treatment modalities, and an increasing focus on personalized medicine. The...
0 التعليقات 0 المشاركات 6 مشاهدة 0 معاينة
Abistem https://abistem.com